Answers are grounded in this paper and cite their sources.
This analysis demonstrates the potential of ferrocenylchalcones against schistosoma mansoni, suggesting new treatment alternatives for schistosomiasis.
Schistosomiasis mansoni is a parasitic disease caused by the trematode Schistosoma mansoni. Currently, the treatment of schistosomiasis is based on the use of just one drug, praziquantel. However, the extensive use of this drug can lead to the selection of tolerant and resistant strains, making it necessary to investigate new chemotherapeutic alternatives. In recent years, chalcones, substances found in various plants and also obtained by synthetic means, have been recognised for their biological activities, including antibacterial, antifungal, antiviral and antiparasitic activities. The aim of this research was to analyse the potential of ferrocenylchalcones against adult S. mansoni worms. The results of this study show that chalcona can be considered a new therapeutic alternative for treating S.mansoni.
No takes yet. Share an insight, caveat, or question.
AÏS et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: